Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clostridium Difficile
Biotech
Finch stops phase 3, lays off 95% of staff and plans asset sale
The microbiome biotech has decided to stop the study and seek to offload assets in the face of a frosty funding forecast and slow enrollment.
Nick Paul Taylor
Jan 24, 2023 10:00am
Summit calls for antibiotic rethink after sharing trial data
Oct 21, 2022 9:51am
Morningside rolls up two biotechs to birth inflammation startup
Mar 10, 2022 9:30am
Pfizer fails C. diff vaccine test but sees possible way forward
Mar 1, 2022 8:20am
